Eagle Health Investments LP United Therapeutics Corp Transaction History

Eagle Health Investments LP

$527 Million
Q3 2024

A detailed history of Eagle Health Investments LP transactions in United Therapeutics Corp stock. As of the latest transaction made, Eagle Health Investments LP holds 54,099 shares of UTHR stock, worth $19.6 Million. This represents 3.68% of its overall portfolio holdings.

Number of Shares

54,099

Previous 167,499 67.7%

Holding current value

$19.6 Million

Previous $53.4 Million 63.67%

% of portfolio

3.68%

Previous 9.37%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$311.04 - $363.55 $35.3 Million - $41.2 Million	-113,400 Reduced 67.7%	54,099 $19.4 Million
Q2 2024 Aug 13, 2024	SELL	$228.26 - $319.04 $2.74 Million - $3.83 Million	-12,000 Reduced 6.69%	167,499 $53.4 Million
Q1 2024 May 14, 2024	BUY	$210.76 - $249.51 $1.83 Million - $2.16 Million	8,661 Added 5.07%	179,499 $41.2 Million
Q2 2023 Aug 14, 2023	BUY	$205.19 - $232.99 $8.13 Million - $9.23 Million	39,600 Added 30.17%	170,838 $37.7 Million
Q4 2022 Feb 13, 2023	SELL	$205.95 - $280.43 $1.96 Million - $2.66 Million	-9,500 Reduced 6.75%	131,238 $36.5 Million
Q3 2022 Nov 14, 2022	SELL	$203.3 - $244.17 $3.76 Million - $4.52 Million	-18,500 Reduced 11.62%	140,738 $29.5 Million
Q1 2022 May 12, 2022	BUY	$166.16 - $213.96 $963,728 - $1.24 Million	5,800 Added 3.78%	159,238 $28.6 Million
Q4 2021 Feb 10, 2022	BUY	$184.32 - $216.08 $10.2 Million - $12 Million	55,400 Added 56.51%	153,438 $33.2 Million
Q2 2021 Jul 19, 2021	BUY	$170.47 - $211.93 $841,780 - $1.05 Million	4,938 Added 5.3%	98,038 $17.6 Million
Q1 2021 Apr 23, 2021	BUY	$153.94 - $174.85 $3.56 Million - $4.04 Million	23,100 Added 33.0%	93,100 $15.6 Million
Q4 2020 Feb 04, 2021	BUY	$101.87 - $151.79 $7.13 Million - $10.6 Million	70,000 New	70,000 $10.6 Million

Others Institutions Holding UTHR

# of Institutions

673

Shares Held

42.2M

Call Options Held

194K

Put Options Held

295K

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.5B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Health Investments LP, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Health Investments LP with notifications on news.

Account

Eagle Health Investments LP United Therapeutics Corp Transaction History